
Aug 18, 2026 · 7 min
Frasers Group nears control of Hugo Boss as rivals stumble
Frasers Group Up, Royal Unibrew Drops, OXB Down
The episode tracks three distinct market signals: a near-controlling stake in Hugo Boss, weak Royal Unibrew earnings, and a downgrade-driven fall for Oxford Biomedica.
- 1Frasers Group raised its Hugo Boss stake to nearly 48%, stopping just short of overall control.
- 2Royal Unibrew came under pressure after disappointing second-quarter earnings.
- 3Oxford Biomedica shares declined after Deutsche Bank downgraded the company.
Don't miss
Frasers Group’s stake in Hugo Boss reaches nearly 48%, just short of overall control.
The brief
Stephen Carroll and Tiwa Adebayo introduce a report on European stocks moving for sharply different reasons, with breaking news editor Louise Moon joining the discussion.
Frasers Group lifted its stake in Germany’s Hugo Boss to nearly 48%, bringing the retailer close to overall control without crossing that line.
Royal Unibrew’s disappointing second-quarter earnings provided a more familiar market signal: weakness in company results can quickly weigh on a stock.
Oxford Biomedica shares fell after Deutsche Bank downgraded the company, adding analyst judgment to the episode’s mix of market-moving catalysts.
Together, the three cases show how ownership moves, earnings performance, and research calls can send European stocks in different directions.
What was said on this episode
3 statements · 1 positive · 2 negative
Hugo Boss shares rose nearly 2% after Frasers Group increased its stake.
“shares higher this morning, just over 1%. Just under 2% higher.”
Listen at 1:11
Royal Unibrew shares fell more than 9%, their largest decline since April.
“shares falling just over 9%. That's the most since April.”
Listen at 2:58
Oxford Biomedica cut its full-year revenue and profitability guidance.
“they cut their full year revenue and profitability guidance.”
Listen at 4:05
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.